HFD-line F9 mice exhibited distinct mRNA expression profiles, with microarray data revealing differential expression in obesity-metabolism pathways, including the insulin signaling pathway, T2DM, glutathione metabolism, circadian rhythm, cholesterol metabolism, glycolysis/gluconeogenesis, insulin secretion, and AMPK signaling pathway. The gene discussed is INS; the disease is obesity disorder.